Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Helsingin Yliopisto currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and is located within 1 distinct art unit. This reflects a highly centralized and singular point of prosecution for the university's current active filings.
The busiest examiner for this portfolio is ANDERSON, REBECCA L, who manages 1 busiest examiner pending action. As the total number of pending office actions is also 1, this examiner is responsible for the university's entire current pending workload. There are no other examiners or art units involved in the current pending docket beyond the 1 distinct examiner and 1 distinct art unit reported.
This data indicates that the university's immediate patent outcomes in the Biotechnology & Pharmaceuticals field depend on a single interaction. Practitioners can focus their efforts on the specific examination style of ANDERSON, REBECCA L. The lack of multiple pending actions or diverse art units simplifies the prosecution landscape, as there are no competing departmental standards to navigate at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ANDERSON, REBECCA L | 1 | 73.4% | +23.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557371 | A SPECIFIC COMBINATION OF LIPIDS AND METHODS AND USES RELATED THERETO | ANDERSON, REBECCA L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557371 | A SPECIFIC COMBINATION OF LIPIDS AND METHODS AND USES RELATED THERETO | ANDERSON, REBECCA L | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18557371 | A SPECIFIC COMBINATION OF LIPIDS AND METHODS AND USES RELATED THERETO | ANDERSON, REBECCA L | 1626 | §103§112Other | Non-Final OA | — | Pending | Oct 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial